ClinicalTrials.gg
RecruitingNCT06834906Updated Aug 15, 2025

Usability User Testing of the Easy-EyeFM AI Platform

An interventional study of EasyEyeFM-AutoML-AI-platform test and AutoML-EasyEyeFM-AI-platform test in Ocular Diseases, sponsored by Tsinghua University. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-08-15.

Sponsored by Tsinghua University · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 2 months ago, but the record still lists the study as recruiting.
  • Started Jan 2025; still recruiting 1 year 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Easy-EyeFM is a code-free artificial intelligence platform designed for ophthalmologists to provide diagnostic and treatment recommendations and help doctors develop customized diagnostic models.

This project aims to evaluate the usability and user-friendliness of the Easy-EyeFM platform for physicians. The study will gather feedback from medical professionals to evaluate the intuitiveness and effectiveness of the platform in supporting model customization and medical image analysis tasks.

Subjects will participate in the trial of the Easy-EyeFM platform and the comparison with the existing commercial platform (AutoML) at the appointed time. The researchers will inform subjects of relevant precautions and assist them to read the user manual before the test. Subjects will complete model customization and picture diagnosis within the prescribed test time, and according to the test results, Score the human-computer interaction experience of the AI platform, fill in the questionnaire, and finally complete the evaluation content.

02

Conditions studied

  • Ocular Diseases
03

In context

Lead sponsor

Tsinghua University is the lead sponsor of 28 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Medical students or doctors
  • Have enough time to participate in this program, about 1 hour continuous assessment
  • Agree to sign the form

Exclusion criteria

Exclusion Criteria:

  • Poor computer and mobile phone use and reading ability
  • Poor language expression or dialect category is not included in the speech recognition function of the platform
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
84 participants (estimated)

Study arms

  • Experimental
    group A

    Diagnostic Test: EasyEyeFM-AutoML-AI-platform test

  • Experimental
    group B

    Diagnostic Test: AutoML-EasyEyeFM-AI-platform test

Interventions

  • Diagnostic testEasyEyeFM-AutoML-AI-platform test

    AI platforms using

  • Diagnostic testAutoML-EasyEyeFM-AI-platform test

    AI-platform using

06

What researchers measure

Primary outcomes

  1. System Usability Scale

    Minimum Value: 0 Maximum Value: 100 Higher scores indicate a better outcome, meaning higher system usability.

    Time frame: 1 day

Secondary outcomes

  1. Usage Time

    Time frame: 1 day

  2. Users Assistance Requests Times

    Time frame: 1 day

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2025 (actual). Primary completion is estimated for Sep 2025, 8 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 9, 2025
First posted
Feb 19, 2025
StartActual
Jan 26, 2025
Primary completionEst.
Sep 2025
CompletionEst.
Sep 2025
Last update
Aug 15, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06834906
Lead sponsor
Tsinghua University
Collaborators
First Hospital of Tsinghua University, Beijing Tsinghua Changgeng Hospital, Augenarzt-Praxisgemeinschaft Gutblick AG, Sankara Nethralaya, Department of Medical Services Ministry of Public Health of Thailand, Moorfields Eye Hospital NHS Foundation Trust, Pomeranian Hospitals, Shanghai Health and Medical Center, Hong Kong Eye Hospital, Royal Victoria Eye and Ear Hospital, Hanyang University Guri Hospital, Al-Shifa Trust Eye Hospital, Korle-Bu Teaching Hospital, Accra, Ghana, Nippon Medical School Tama Nagayama Hospital
Responsible party
Tien Yin Wong (Professor, Tsinghua University) — Principal investigator
First posted
Feb 19, 2025
Start date
Jan 26, 2025
Primary completion
Sep 2025 (estimated)
Completion
Sep 2025 (estimated)
Last update
Aug 15, 2025

Study contacts

Jinyuan Wang
Contact
jinyuanwang@tsinghua.edu.cn
086-15801191316
Tien Yin Wong
principal investigator · Tsinghua University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion